Çakır Caner, Yüksel Dilek, Kılıç Çiğdem, Ünsal Mehmet, Dur Rıza, Boyraz Gökhan, Karalok Alper, Moraloğlu Tekin Özlem, Turan Taner
Etlik Zübeyde Hanım Women's Health Training and Research Hospital, Clinic of Gynecologic Oncology, Ankara, Turkey.
Turk J Obstet Gynecol. 2019 Dec;16(4):266-270. doi: 10.4274/tjod.galenos.2019.26932. Epub 2020 Feb 28.
To present the clinical, surgical, and pathologic features of bone recurrence in patients who underwent radical hysterectomy for early-stage uterine cervical cancer.
Data of 412 patients who underwent type III radical hysterectomy and pelvic ± paraaortic lymphadenectomy for stage 1B-2A epithelial cervical cancer were reviewed. Seven (1.7%) patients with bone recurrence in the first recurrence were included in the study.
The median follow-up of the main cohort (n=412) was 46 (range=1-300) months. In this period, recurrence developed in 53 (12.9%) patients and recurrence was observed in bone in 13.2% (7 of 53) of these recurrences. Time to recurrence ranged from 9 to 45 months. Of the recurrences, five were in the axial skeleton and two were in the appendicular skeleton. Recurrence was observed in lumbar vertebrae in three patients, thoracic vertebrae in one patient, sacral vertebrae in one patient, lumbosacral vertebrae in one patient, and the left femur in two patients. Four patients had multiple recurrence in 3 patients despite isolated bone recurrence. Patients with multiple recurrences died within 6-25 months. All isolated bone recurrences were in the axial skeleton. Complete clinical response with salvage therapy was achieved in two patients with isolated bone recurrence.
Complete clinical response and long postoperative survival can be achieved with salvage treatment when bone recurrence is solitary in cervical cancers.
介绍早期子宫颈癌行根治性子宫切除术后患者骨转移复发的临床、手术及病理特征。
回顾了412例行III型根治性子宫切除术及盆腔±腹主动脉旁淋巴结清扫术治疗1B - 2A期上皮性宫颈癌患者的数据。7例(1.7%)首次复发为骨转移的患者纳入本研究。
主要队列(n = 412)的中位随访时间为46个月(范围 = 1 - 300个月)。在此期间,53例(12.9%)患者出现复发,其中13.2%(53例中的7例)复发部位为骨转移。复发时间为9至45个月。在这些复发患者中,5例发生在中轴骨骼,2例发生在四肢骨骼。3例患者复发于腰椎,1例患者复发于胸椎,1例患者复发于骶椎,1例患者复发于腰骶椎,2例患者复发于左股骨。4例患者虽为孤立性骨转移复发,但有3例出现多处复发。多处复发的患者在6至25个月内死亡。所有孤立性骨转移复发均发生在中轴骨骼。2例孤立性骨转移复发患者经挽救性治疗后获得了完全临床缓解。
宫颈癌骨转移复发为孤立性时,挽救性治疗可实现完全临床缓解及较长的术后生存期。